Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 15, 2023
SUV<sub>max</sub> Above 20 in <sup>18</sup>F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
Gregor Zaun, Manuel Weber, Martin Metzenmacher, et al.
Clinical Colorectal Cancer
|
August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial
Stefan Kasper, Johannes Meiler, Heike Knipp, et al.
Clinical Lung Cancer
|
April 11, 2018
MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
Henning Reis, Martin Metzenmacher, Moritz Goetz, et al.
Oncology Research and Treatment
|
January 31, 2023
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
Julius Roehrle, Stefan Kasper, Jürgen-Walter Treckmann, et al.
Cambridge Prisms. Precision Medicine
|
November 27, 2025
Accelerating eSource scale-up in oncology clinical trials: The i~HD Task Force initiative
Christophe Maes, Dipak Kalra, Tracy Acito, et al.
Nature Communications
|
March 2, 2017
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression
Halime Kalkavan, Piyush Sharma, Stefan Kasper, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 15, 2023
SUV<sub>max</sub> Above 20 in <sup>18</sup>F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
Gregor Zaun, Manuel Weber, Martin Metzenmacher, et al.
Clinical Colorectal Cancer
|
August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial
Stefan Kasper, Johannes Meiler, Heike Knipp, et al.
Clinical Lung Cancer
|
April 11, 2018
MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
Henning Reis, Martin Metzenmacher, Moritz Goetz, et al.
Oncology Research and Treatment
|
January 31, 2023
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
Julius Roehrle, Stefan Kasper, Jürgen-Walter Treckmann, et al.
Cambridge Prisms. Precision Medicine
|
November 27, 2025
Accelerating eSource scale-up in oncology clinical trials: The i~HD Task Force initiative
Christophe Maes, Dipak Kalra, Tracy Acito, et al.
Nature Communications
|
March 2, 2017
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression
Halime Kalkavan, Piyush Sharma, Stefan Kasper, et al.
Page
of 2